Onaiza Cadoret-Manier - Jan 11, 2023 Form 4/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Jan 11, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/27/2023, 05:11 PM
Date Of Original Report
Jan 12, 2023
Previous filing
Jan 5, 2023
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTYX Stock Option (right to buy) Award $0 +20.4K $0.00 20.4K Jan 11, 2023 Common Stock 20.4K $34.16 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed on January 12, 2023, erroneously reported that reporting person received an option award for 12,880 shares on January 11, 2023. The correct option award amount is for 20,427 shares.
F2 One-thirty sixth (1/36th) of the Shares subject to the option will be scheduled to vest each month following the grant date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through the applicable vesting date.